# Meropenem

## Mepem inj 0.25gm

| 藥物代碼 | IMEP2 |
| :--- | :--- |
| 適應症 | Bacterial meningitis: Treatment of bacterial meningitis in pediatric patients 3 months and older caused by Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidisComplicated skin and skin structure infections: Treatment of complicated skin and skin structure infections in adults and pediatric patients 3 months and older caused by Staphylococcus aureus \(methicillin-susceptible isolates only\), Streptococcus pyogenes, S. agalactiae, viridans group streptococci, Enterococcus faecalis \(vancomycin-susceptible isolates only\), Pseudomonas aeruginosa, Escherichia coli, Proteus mirabilis, Bacteroides fragilis, and Peptostreptococcus speciesIntra-abdominal infections: Treatment of complicated appendicitis and peritonitis in adult and pediatric patients caused by viridans group streptococci, E. coli, Klebsiella pneumoniae, P. aeruginosa, B. fragilis, B. thetaiotaomicron, and Peptostreptococcus speciesCanadian labeling: Additional indications \(not in U.S. labeling\): Treatment of lower respiratory tract infections \(community-acquired and nosocomial pneumonias\), uncomplicated skin and skin structure infections, complicated urinary tract infections, gynecologic infections \(excluding chlamydia\), and septicemia; treatment of bacterial meningitis in adults caused by S. pneumoniae, H. influenzae, and N. meningitidis \(use in adult meningitis based on pediatric data\) |
| 副作用 | Shock, serious renal disorders including acute renal failure, serious colitis accompanied with bloody stool, pseudomembranous colitis, interstitial pneumonia & PIE syndrome. CNS convulsion e.g. seizures, consciousness disorders. Lyell syndrome, Steven-Johnson syndrome, pancytopenia, agranulocytosis, leucopenia, hepatic disorders, jaundice, rash, urticaria, feeling of warmth, erythema, pruritus, fever & redness. Granulocytopenia, eosinophilia, thrombocytopenia or thrombocytosis & lymphocytosis increased GOT/GPT/LDH/A1-P/LAP/γ-GTP/bilirubin/urinary urobilinogen, decreased cholinesterase, increased urinary β2-microglobulin/BUN/creatinine, abdominal pain, diarrhea, nausea, vomiting & anorexia, stomatitis, candidiasis, vit K deficiency symptoms, vit B complex deficiency symptoms, headache, malaise.Dermatologic: Injection site inflammation \(2.4% \)Gastrointestinal: Constipation \(1.4% to 7% \), Diarrhea \(3.5% to 7% \), Nausea and vomiting \(3.6% adults; 0.8% children \)Neurologic: Headache \(2.3% to 7.8% \) |
| 禁忌 | Hypersensitivity to meropenem, other drugs in the same class, or any component of the formulation; patients who have experienced anaphylactic reactions to beta-lactams |
| 懷孕用藥危分級 | 除非治療上需要 |
| 孕期用藥建議 | No \(Limited\) Human Data - animal data suggest low risk |
| 附帶說明 | N/A |
| 哺乳期用藥建議 | No \(Limited\) Human Data - Probably Compatible 無\(很少\)資料 - 可使用 |
| 附帶說明 | N/A |
| 注射劑給藥建議途徑 | IVD |
| 乾粉稀釋液 | IVD: 5mL N/S |
| 輸注點滴液 | 【N/S】 可選 |
| IVP 用法建議 | N/A |
| IVD 用法建議 | 通常給藥濃度≦5mg/mL，建議以&gt;30分鐘緩慢滴注. \[Micromedex\] solutions diluted with NS ranging from 1 to 20 mg/mL; may store for 1 hour at room temperature or for 15 hours refrigerated. |
| 注意事項 | 1. 監測體溫、CBC、肝腎功能，注意是否有肌肉震顫或癲癇發作徵狀。 2. 給藥後第3 ~ 5天應特別觀察皮疹等不良反應。 3. Meropenem 0.25 gm/vial 乾粉使用100 mL適當輸注液稀釋，靜脈點滴輸注 &gt; 30分鐘給藥。 |

